No Data
Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders
US MOVERS&SHAKERS Jun 24-Jun 28, 2024
Here are the top 10 gainers and losers of the week.
Alnylam Pharmaceuticals Is Maintained at Buy by UBS
Alnylam Pharmaceuticals Is Maintained at Buy by UBS
Express News | Alnylam Pharmaceuticals Inc : UBS Raises Target Price to $288 From $253
UBS Initiates Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $288
UBS analyst Eliana Merle initiates coverage on $Alnylam Pharmaceuticals(ALNY.US)$ with a buy rating, and sets the target price at $288.According to TipRanks data, the analyst has a success rate of 40.
Alnylam Pharmaceuticals(ALNY.US) Director Sells US$2.04 Million in Common Stock
$Alnylam Pharmaceuticals(ALNY.US)$ Director SCHULMAN AMY W sold 8,500 shares of common stock on Jun 25, 2024 at an average price of $240 for a total value of $2.04 million.Source: Announcement What is